About

About SyVento BioTech SyVento BioTech is an innovative biotech partner offering end-to-end capabilities to develop, formulate and manufacture next-generation mRNA-based products and innovative medicines. Leveraging unique know-how and customer-centric flexibility, the company delivers comprehensive services, including preclinical/clinical drug development, RUO/GMP-grade mRNA synthesis, manufacturing of GMP commercial/clinical batches, and aseptic fill & finish—all under one roof. With a state-of-the-art facility located in the EU (Poland), SyVento BioTech specializes in liposomal and LNP technology, providing tailored solutions for the encapsulation and delivery of therapeutic molecules, such as: RNA, DNA, CRISPR, small molecules, proteins and peptides. The company supports customers on each step of the project, including quality control, analytics, bioassay, regulatory support, warehousing and project management. SyVento BioTech is an innovative biotech partner offering end-to-end capabilities to develop, formulate and manufacture next-generation mRNA-based products and innovative medicines. Leveraging unique know-how and customer-centric flexibility, the company delivers comprehensive services, including preclinical/clinical drug development, RUO/GMP-grade mRNA synthesis, manufacturing of GMP commercial/clinical batches, and aseptic fill & finish - all under one roof. With a state-of-the-art facility located in the EU (Poland), SyVento BioTech specializes in liposomal and LNP technology, providing tailored solutions for the encapsulation and delivery of therapeutic molecules, such as: RNA, DNA, CRISPR-Cas9, small molecules, proteins and peptides. The company supports customers on each step of the project, including quality control, analytics, bioassay, regulatory support, warehousing and project management.